Playback speed
10 seconds
AHA 2022: Sotagliflozin, a Dual SGLT-1/2 Inhibitor, Modulated Expression of Endothelial Proteins That Inhibit Reactive Oxygen Species During Inflammation Compared With Empagliflozin
By
AHA 2022 Conference Coverage
FEATURING
R. Preston Mason
By
AHA 2022 Conference Coverage
FEATURING
R. Preston Mason
373 views
November 16, 2022
Login to view comments.
Click here to Login